Skip to main content
    • Aa
    • Aa

Botulinum toxin A injection into corrugator muscle for frontally localised chronic daily headache or chronic tension-type headache

  • J A de Ru (a1) and J Buwalda (a1)

To describe our results with botulinum toxin type A injection for headache in carefully selected patients, and to present the rationale behind this therapy.


Tertiary referral centre.

Patients and methods:

This article describes a case series of 10 consecutive patients with frontally localised headache, whose pain worsened when pressure was applied at the orbital rim near the supratrochlear nerve. The patients received a local anaesthetic nerve block with Xylocaine 2 per cent at this site. If this reduced the pain, they were then offered treatment with botulinum toxin.


Injection with 12.5 IU of botulinum toxin A into the corrugator supercilii muscle on both sides (a total of 25 IU).

Main outcome measure:

Pain severity scoring by the patients, ranging from zero (no pain) to 10 (severe pain) on a verbal scale.


Following injection, all patients had less pain for approximately two months. This treatment did not appear to have lasting side effects.


Xylocaine injection is a good predictor of the effectiveness of botulinum toxin injection into the corrugator muscle as treatment of frontally localised headache. We hypothesise that this pain is caused by entrapment of the supratrochlearis nerve in the corrugator muscle. Furthermore, we found botulinum toxin injection to be a safe and effective means of achieving pain relief in this patient group.

Corresponding author
Address for correspondence: Dr J A de Ru, ENT Surgeon, Department of Otolaryngology-Head Neck Surgery, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands. Fax: 0031 302541922 E-mail:
Linked references
Hide All

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.

1DW Dodick , A Mauskop , AH Elkind , R DeGryse , MF Brin , SD Silberstein . Botulinum toxin type A for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study. Headache 2005;45:315–24

2A Pakalnis , J Couch . Headache therapy with botulinum toxin: form over substance. Arch Neurol 2008;65:149–51

3NT Mathew , BM Frishberg , M Gawel , R Dimitrova , J Gibson , C Turkel . Botulinum toxin type A (Botox) for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial. Headache 2005;45:293307

4SD Silberstein , SR Stark , SM Lucas , SN Christie , RE DeGryse . Botulinum toxin type A for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial. Mayo Clin Proc 2005;80:1126–37

5BS Schwartz , WF Stewart , D Simon , RB Lipton . Epidemiology of tension-type headache. JAMA 1998;279:381–3

6M Padberg , SFTM De Bruijn , RJ De Haan , DLJ Tavy . Treatment of chronic tension-type headache with botulinum toxin: a double-blind, placebo-controlled clinical trial. Cephalalgia 2004;24:675–80

7JD Rollnik , O Tanneberger , M Schubert , U Schneider , R Dengler . Treatment of tension-type headache with botulinum toxin type A: a double blind, placebo-controlled study. Headache 2000;40:300–5

9WJ Binder , MF Brin , A Blitzer , LD Schoenrock , JM Pogoda . Botulinum toxin type A (Botox) for treatment of migraine headaches: an open-label study. Otolaryngol Head Neck Surg 2000;123:669–76

10N Barrientos , P Chana . Botulinum toxin type A in prophylactic treatment of migraine headaches: a preliminary study. J Headache Pain 2003;4:146–51

11WJ Schulte-Mattler , P Krack . Treatment of chronic tension-type headache with botulinum toxin A: a randomized, double blind, placebo-controlled multicenter study. Pain 2004;109:110–4

12EJ Eross , JP Gladstone , S Lewis , R Rogers , DW Dodick . Duration of migraine is a predictor for response to botulinum toxin type A. Headache 2005;45:308–14

13A Ashkenazi , SD Silberstein . Botulinum toxin and other new approaches to migraine therapy. Ann Rev Med 2004;55:505–8

14A Ashkenazi , S Silberstein . Botulinum toxin type A for the treatment of headache: why we say yes. Arch Neurol 2008;65:146–9

15ES Roach . Questioning botulinum toxin for headache: reality or illusion. Arch Neurol 2008;65:151–2

16F Dirnberger , K Becker . Surgical treatment of migraine headaches by corrugator muscle resection. Plast Reconstr Surg 2004;114:652–7

17WH Bearden , RL Anderson . Corrugator superciliaris muscle excision for tension and migraine headaches. Ophthal Plast Reconstr Surg 2005;21:418–22

19B Guyuron , A Varghai , BJ Michelow , T Thomas , J Davis . Corrugator supercilii muscle resection and migraine headaches. Plast Reconstr Surg 2000;106:429–34

20B Guyuron , T Tucker , J Davis . Surgical treatment of migraine headaches. Plast Reconstr Surg 2002;109:2183–9

21TJ Schwedt , JG Hentz , DW Dodick . Factors associated with the prophylactic effect of placebo injections in subjects enrolled in a study of botulinum for migraine. Cephalalgia 2007;27:528–34

22S Evers , J Olesen . Reply: letters to the editor. Cephalalgia 2007;27:468

23WJ Schmitt , E Slowey , N Fravi , S Weber , J-M Burgunder . Effect of botulinum toxin A injections in the treatment of chronic tension-type headache: a double-blind, placebo-controlled trial. Headache 2001;41:658–64

24RA Behmand , T Tucker , B Guyuron . Single-site botulinum toxin type A injection for elimination of migraine trigger points. Headache 2003;43:1085–9

25JA Smuts , D Schultz , A Barnard . Mechanism of action of botulinum toxin type A in migraine prevention: a pilot study. Headache 2004;44:801–5

26S Mosser , B Guyuron , J Janis , R Rohrich . The anatomy of the greater occipital nerve: implications for the etiology of migraine headaches. Plast Reconstr Surg 2004;113:693–7

27C Fernández de las Peñas , ML Cuadrado , L Arendt Nielsen , DG Simons , JA Pareja . Myofascial trigger points and sensitization: an updated pain model for tension-type headache. Cephalalgia 2007;27:383–93

29JM McPartland , DG Simons . Myofascial trigger points: translating molecular theory into manual therapy. J Man Manipul Therapy 2006;14:232–9

30K-Y Ho , K-H Tan . Botulinum toxin A for myofascial trigger point injection: a qualitative systematic review. Eur J Pain 2007;11:519–27

31T Muehlberger , P Fisher , M Lehnhardt . The anatomy of the surgical treatment of migraine [in German]. Zentralbl Chir 2005;130:288–92

32JJ Dutton , AM Fowler . Botulinum toxin in ophthalmology. Surv Ophthalmol 2007;52:1331

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

The Journal of Laryngology & Otology
  • ISSN: 0022-2151
  • EISSN: 1748-5460
  • URL: /core/journals/journal-of-laryngology-and-otology
Please enter your name
Please enter a valid email address
Who would you like to send this to? *